$ヴィーナス・コンセプト(VERO.US)$Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ:VERO), a global medical aesthetic technology leader, today announced that it has received approval for the Venus Bliss MAX from the State of Israel Ministry of Health. The Venus Bliss MAX was first launched commercially in the United States in Q1 2022 after FDA 510(k) clearance and offered internationally in approved jurisdictions.
Venus Concept Inc. (NASDAQ: VERO), a prominent player in the global medical aesthetics market, has recently announced that it has obtained the CE Mark for its innovative device Venus Versa Pro in Europe. This announcement heralds a significant milestone in the company's journey, paving the way for further expansion into the European market.$ヴィーナス・コンセプト(VERO.US)$ https://stockregion.app/p/global-medical-aesthetics-company
$ヴィーナス・コンセプト(VERO.US)$Venus Concept Shares Are Trading Higher After the Company Announced It Received the CE Mark From DEKRA Certification B.V. to Market the Venus Versa Pro System in the European Union
ヴィーナス・コンセプトに関するコメント
Update
Bust
Global Medical Aesthetics Company Announces Milestone Expansion.
https://stockregion.app/p/global-medical-aesthetics-company
6000 shares buying
🔥🚀🌖
increasing green candle to 2.20
まだコメントはありません